Yahoo
NasdaqCM - Delayed Quote USD

Health In Tech, Inc. (HIT)

0.5773 -0.0549 (-8.68%)
At close: October 30 at 4:00:01 PM EDT
Trade HIT on Coinbase
Chart Range Bar
Loading chart for HIT
  • Previous Close 0.6322
  • Open 0.6300
  • Bid 0.5835 x 200
  • Ask 1.0100 x 200
  • Day's Range 0.5772 - 0.6460
  • 52 Week Range 0.5000 - 3.1100
  • Volume 25,147
  • Avg. Volume 175,409
  • Market Cap (intraday) 37.698M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0700
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 3.12
  • Motley Fool Rating Bullish

Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

healthintech.com

87

Full Time Employees

December 31

Fiscal Year Ends

Technology

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HIT
63.69%
S&P 500 (^GSPC)
10.73%

1-Year Return

HIT
77.88%
S&P 500 (^GSPC)
11.11%

3-Year Return

HIT
89.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

HIT
89.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 8.77M
Earnings -1.59M
Profit Margin -18.11%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
2M
4M
6M
8M
-15.0%
-10.0%
-5.0%
0.0%
5.0%

Analyst Insights

View More

Analyst Price Targets

1.25
3.12 Average
0.5773 Current
4.10 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/14/2026
Analyst Maxim Group
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 4 -> 3

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.03%

  • Return on Assets (ttm)

    -12.72%

  • Return on Equity (ttm)

    -21.91%

  • Revenue (ttm)

    32.83M

  • Net Income Avi to Common (ttm)

    -3.95M

  • Diluted EPS (ttm)

    -0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.51M

  • Total Debt/Equity (mrq)

    0.52%

  • Levered Free Cash Flow (ttm)

    -6.67M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: